tradingkey.logo
tradingkey.logo
Search

Vyne Therapeutics Inc

VYNE
Add to Watchlist
28.560USD
0.0000.00%
Market hours ET
110.85MMarket Cap
LossP/E TTM

VYNE Financials

See Vyne Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
110.85M
Dividend TTM
0.00
P/E TTM
-56.98
EPS TTM
-0.50
Revenue
570.00K
Net Profit
-39.83M
ROE
-63.16%
ROA
-52.78%

Vyne Therapeutics Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.08/-0.18
Revenue / Forecast
86.00K/200.00K

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-2503.95%-3.50
-1976.91%-4.19
60.01%-0.11
40.42%-0.17
39.06%-0.13
-37.50%-0.20
-42.72%-0.28
85.77%-0.29
92.81%-0.22
91.50%-0.15
93.59%-0.20
---2.01
---3.07
---1.73
---3.08
---4.18
----
----
----
----
Revenue
40.58%97.00K
-57.43%86.00K
54.76%130.00K
39.67%169.00K
-65.15%69.00K
106.12%202.00K
10.53%84.00K
6.14%121.00K
46.67%198.00K
-1.01%98.00K
1166.67%76.00K
-31.74%114.00K
7.14%135.00K
-44.38%99.00K
-99.74%6.00K
-95.91%167.00K
-57.29%126.00K
-22.61%178.00K
-46.52%2.29M
24.99%4.09M
Net Profit
47.75%-3.01M
58.37%-3.58M
59.77%-4.84M
40.12%-7.28M
38.82%-5.75M
-37.80%-8.61M
-94.28%-12.02M
-84.64%-12.16M
6.48%-9.41M
-11.15%-6.25M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
14.04%-9.95M
55.56%-9.46M
57.46%-8.48M
122.73%4.67M
50.09%-11.57M
13.87%-21.29M
Net Margin
64.12%-2988.66%
2.12%-4168.60%
73.32%-3815.38%
56.27%-4394.08%
-75.53%-8328.99%
33.12%-4258.91%
-76.69%-14302.38%
-88.66%-10047.11%
36.19%-4744.95%
-12.34%-6368.37%
93.74%-8094.74%
---5325.44%
---7435.56%
---5668.69%
---129350.00%
---5559.24%
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
Revenue
40.58%97.00K
-57.43%86.00K
54.76%130.00K
39.67%169.00K
-65.15%69.00K
106.12%202.00K
10.53%84.00K
6.14%121.00K
46.67%198.00K
-1.01%98.00K
1166.67%76.00K
-31.74%114.00K
7.14%135.00K
-44.38%99.00K
-99.74%6.00K
-95.91%167.00K
-57.29%126.00K
-22.61%178.00K
-46.52%2.29M
24.99%4.09M
Operating profit
58.87%-3.10M
58.51%-3.82M
59.13%-5.22M
40.48%-7.79M
27.45%-7.54M
-24.62%-9.20M
-86.91%-12.77M
-109.99%-13.09M
-0.76%-10.40M
-25.62%-7.38M
14.43%-6.83M
33.20%-6.23M
-24.51%-10.32M
32.40%-5.88M
33.71%-7.98M
47.50%-9.33M
13.15%-8.29M
10.93%-8.69M
45.23%-12.04M
24.33%-17.78M
Net Profit
47.75%-3.01M
58.37%-3.58M
59.77%-4.84M
40.12%-7.28M
38.82%-5.75M
-37.80%-8.61M
-94.28%-12.02M
-84.64%-12.16M
6.48%-9.41M
-11.15%-6.25M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
14.04%-9.95M
55.56%-9.46M
57.46%-8.48M
122.73%4.67M
50.09%-11.57M
13.87%-21.29M
Current assets
-46.95%23.53M
-53.04%25.79M
-53.43%30.01M
-51.20%35.89M
-47.07%44.34M
-39.14%54.91M
-32.85%64.44M
319.94%73.53M
264.89%83.78M
173.22%90.22M
150.72%95.96M
-60.24%17.51M
-55.78%22.96M
-45.56%33.02M
-39.42%38.27M
-42.14%44.05M
-59.57%51.92M
-57.62%60.65M
-27.59%63.19M
-22.45%76.13M
Total current liabilities
-73.58%1.54M
-89.94%1.24M
-83.84%2.40M
-68.06%4.04M
-50.35%5.84M
77.36%12.29M
96.59%14.82M
96.33%12.66M
84.41%11.75M
-7.83%6.93M
-19.34%7.54M
-5.70%6.45M
-6.74%6.37M
-12.45%7.52M
-49.24%9.35M
-67.43%6.84M
-88.14%6.83M
-60.15%8.59M
-15.41%18.41M
-9.46%21.00M
Total assets
-47.22%23.60M
-54.14%25.87M
-54.92%30.16M
-52.58%36.13M
-48.39%44.72M
-38.45%56.42M
-31.51%66.91M
295.48%76.20M
247.16%86.65M
159.98%91.68M
139.67%97.69M
-58.93%19.27M
-54.78%24.96M
-45.17%35.26M
-39.21%40.76M
-42.31%46.91M
-58.81%55.19M
-56.88%64.32M
-28.48%67.05M
-24.49%81.31M
Total liabilities
-73.58%1.54M
-89.94%1.24M
-83.84%2.40M
-68.06%4.04M
-50.45%5.84M
47.98%12.29M
65.58%14.82M
63.12%12.66M
53.23%11.78M
-5.96%8.31M
-4.23%8.95M
13.50%7.76M
12.47%7.69M
2.84%8.83M
-49.24%9.35M
-69.51%6.84M
-88.43%6.83M
-84.74%8.59M
-67.27%18.41M
-61.44%22.43M
Total equity
-43.26%22.06M
-44.17%24.64M
-46.69%27.77M
-49.50%32.09M
-48.07%38.88M
-47.06%44.13M
-41.30%52.09M
452.26%63.54M
333.47%74.87M
215.43%83.37M
182.48%88.73M
-71.29%11.51M
-64.28%17.27M
-52.57%26.43M
-35.41%31.41M
-31.95%40.07M
-35.43%48.36M
-40.01%55.73M
29.72%48.64M
18.92%58.89M
Net operating income
81.56%-1.99M
64.39%-4.08M
58.17%-3.76M
16.62%-7.10M
-27.38%-10.80M
-43.59%-11.46M
-75.18%-9.00M
-65.18%-8.51M
11.42%-8.48M
-45.71%-7.98M
-32.57%-5.14M
16.76%-5.15M
-16.40%-9.57M
39.40%-5.48M
61.32%-3.88M
64.72%-6.19M
49.41%-8.22M
27.98%-9.04M
60.52%-10.02M
25.79%-17.54M
Net investment
-93.58%300.00K
-76.30%4.70M
-33.58%8.46M
191.25%4.40M
-75.42%4.67M
655.65%19.83M
120.43%12.74M
---4.82M
--19.02M
-171.38%-3.57M
-6568.88%-62.35M
100.00%0.00
--0.00
-68.26%5.00M
---935.00K
---1.02M
-100.00%0.00
--15.75M
-100.00%0.00
--0.00
Net financing
58.82%-14.00K
82.76%-15.00K
88.64%-15.00K
-250.00%-7.00K
-1033.33%-34.00K
-2075.00%-87.00K
-100.16%-132.00K
95.74%-2.00K
40.00%-3.00K
98.16%-4.00K
39641.83%82.66M
-80.77%-47.00K
91.80%-5.00K
-114.16%-217.00K
647.37%208.00K
99.92%-26.00K
52.71%-61.00K
-97.92%1.53M
-100.48%-38.00K
-41025.61%-33.56M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its total revenue reached 570.00K, with a year-on-year change of 501.00K.

What are the current assets of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its current assets were 30.01M, with a year-on-year change of -53.43.

What are the total assets of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its total assets of Vyne Therapeutics Inc were 30.16M, with a year-on-year change of -54.92.

What are the total liabilities of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its total liabilities of Vyne Therapeutics Inc were 2.40M, with a year-on-year change of -83.84.

What is the total equity of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its total equity of Vyne Therapeutics Inc was 27.77M, with a year-on-year change of -46.69.

What is the net operating income of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its net operating income of Vyne Therapeutics Inc was -29.75M, with a year-on-year change of 31.83.

What is the net investment of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its net investment of Vyne Therapeutics Inc was 37.37M, with a year-on-year change of 59.93.

What is the net financing of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its net financing of Vyne Therapeutics Inc was -143.00K, with a year-on-year change of -1.42.

What is the Earnings Per Share (EPS) of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -30.96, with a year-on-year change of -3210.24.

What is the net income of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its net income was -26.48M, with a year-on-year change of 33.52.

What is the net margin of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its net profit margin was -4690.53, with a year-on-year change of 40.97.

What is the Return on Equity (ROE) of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -66.96, with a year-on-year change of -18.45.

What is the Return on Assets (ROA) of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -55.09, with a year-on-year change of -13.89.

What is the operating profit of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2025 earnings report, its operating profit was -29.75M, with a year-on-year change of 31.83.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.